Hugh Auchincloss has been Fauci's number two at the National Institutes of Health (NIH) agency since 2006, giving him considerable influence over the federal agency's vaccine policies during the COVID-19 pandemic and push more with the Chinese Communist Party on research.
Greenleaf Health
- The company describes itself as a leading FDA regulatory consulting firm that provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies
- They work on behalf of clients to provide assistance with “drug and biological products”
- Executive Vice President of the firm claims to be an alum of the FDA’s Office of Vaccine Research and Review
- Former Deputy Chief of Staff at the FDA Kalah Auchincloss has 15 years of food and drug legal, policy, and regulatory experience
- Claims to have worked with senior FDA leadership to manage crises, develop policy decisions, implement communications strategies, and liaise with the Department of Health and Human Services
No comments:
Post a Comment